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Available online 25 June 2016FunctionalMRI (fMRI) iswell-established for the study of brain function in healthy populations, although its clin-
ical application has provenmore challenging. Speciﬁcally, cerebrovascular reactivity (CVR), which allows the as-
sessment of the vascular response that serves as the basis for fMRI, has been shown to be reduced inhealthy aging
aswell as in a range of diseases, including chronic stroke. However, the timing of when this occurs relative to the
stroke event is unclear. We used a breath-hold fMRI task to evaluate CVR across gray matter in a group of acute
stroke patients (b10 days from stroke; N= 22) to address this question. These estimates were compared with
those from both age-matched (N = 22) and younger (N = 22) healthy controls. As expected, young controls
had the greatest mean CVR, as indicated by magnitude and extent of fMRI activation; however, stroke patients
did not differ from age-matched controls.Moreover, the ipsilesional and contralesional hemispheres of stroke pa-
tients did not differ with respect to any of these measures. These ﬁndings suggest that fMRI remains a valid tool
within the ﬁrst few days of a stroke, particularly for group fMRI studies in which ﬁndings are compared with
healthy subjects of similar age. However, given the relatively high variability in CVR observed in our stroke sam-
ple, caution is warranted when interpreting fMRI data from individual patients or a small cohort. We conclude
that a breath-hold task can be a useful addition to functional imaging protocols for stroke patients.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
fMRI
Vascular reactivity
Stroke
Breath-hold
Neurovascular uncoupling1. Introduction
Functional magnetic resonance imaging (fMRI) has made important
contributions to our understanding of post-stroke brain changes. fMRI
can provide valuable insight in terms of characterizing brain plasticity
changes as well as the prediction of outcomes and assessment of recov-
ery after stroke (Calautti and Baron, 2003; Heiss and Kidwell, 2014;
Ward et al., 2003). However, there is growing concern over the integrity
of the blood oxygenation level-dependent (BOLD) signal, which is sen-
sitive to changes in cerebral blood ﬂow and volume in addition to the
rate of oxygen metabolism, in stroke patients and other groups who
may exhibit impairments in cerebrovascular reactivity (CVR)—the abil-
ity of cerebral microvasculature to modulate blood ﬂow in response to
vasodilatory stimuli, such as neural activity (D'Esposito et al., 2003;
Girouard and Iadecola, 2006; Lindauer et al., 2010). Such impairments
may manifest as an uncoupling of neural and vascular activity that can
preclude the hemodynamic response from reaching a designated
threshold during a typical task-fMRI paradigm, especially when as-
sumed to match that of young, healthy subjects (Amemiya et al.,iversity ofWisconsin-Madison,
. This is an open access article under2012; Mazzetto-Betti et al., 2010). The resulting false negatives in the
BOLD signal can be misleading to both researchers and clinicians
attempting to map changes in brain function after stroke. It is therefore
crucial to assess the risk of neurovascular uncoupling (NVU) in stroke
patients, and in turn, the validity of BOLD fMRI in this group.
Many studies have sought to assess the validity of fMRI in cerebro-
vascular patients, often observing a delayed, attenuated, or absent he-
modynamic response to behavioral tasks with fMRI (Bonakdarpour et
al., 2007; Krainik et al., 2005; Murata et al., 2006; Pineiro et al., 2002),
even when a neural response is measured by other means (Amemiya
et al., 2012; Binkofski and Seitz, 2004; Bonakdarpour et al., 2015;
Mazzetto-Betti et al., 2010; Rossini et al., 2004). However, a majority
have focused almost exclusively on the chronic stage (Bonakdarpour
et al., 2015; Bonakdarpour et al., 2007; Krainik et al., 2005;
Mazzetto-Betti et al., 2010; Rossini et al., 2004), several weeks to
months from the stroke. Because functional imaging is often performed
just days after a stroke (i.e., at the acute stage), it is critical to determine
if NVU is already a signiﬁcant concern at this point. Since CVRmay con-
tinue to change throughout the course of stroke recovery (Beaulieu et
al., 1999; Siegel et al., 2015; Widder et al., 1994), it is plausible that
NVU may be only transient in stroke patients, increasing conﬁdence in
fMRI data obtained either before or after a certain risk period. Two lon-
gitudinal evaluations of the BOLD signal after stroke have supported thisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Patient characteristics.
Patient Sex
Age
(years)
Time since
stroke
(days) Lesion location
NIH Stroke
Scale score Treatment
1 M 75 6 C; L occipital 1 tPA + ST
2 M 69 4 L cerebellum,
occipital
0 ST
3 M 74 7 C; R temporal,
occipital
1 ST
4 F 44 5 C; L insula,
frontal
7 ST
5 M 45 3 L cerebellum 2 ST
6 M 55 3 C; L MCA and
MCA/PCA border
0 ST
7 M 62 9 C; L parietal 0 ST
8 M 58 5 C; L corticospinal
tract, cerebellum
0 ST
9 F 59 7 C; R MCA 2 tPA + ST
10 M 59 4 C; R MCA 2 tPA + ST
11 M 57 3 SC; R pontine 2 ST
12 M 63 5 SC; R pontine 0 ST
13 F 47 9 C; R frontal 0 ST
14 F 58 7 C; L frontal 1 ST
15 F 59 2 C; L posterior
insular, parietal
2 ST
16 F 46 0 R cerebellum 2 ST
17 M 67 5 SC; L lateral
medulla
0 ST
18 M 63 3 C; R MCA 0 ST
19 F 57 6 L cerebellum 1 ST
20 M 63 2 SC; L posterior
putamen
2 ST
21 M 46 3 C; R occipital 0 tPA + ST
22 F 67 5 C; R MCA 4 tPA + ST
C, cortical; SC, subcortical; L, left; R, right; MCA, middle cerebral artery; PCA, posterior ce-
rebral artery; tPA, tissue plasminogen activator; ST, standard of care stroke treatment (in
most cases consisted of antiplatelet agent (e.g., aspirin, clopidogrel), anticoagulant (e.g.
heparin, warfarin), anti-hypertensive (e.g., beta blocker, angiotensin-converting-enzyme
inhibitor, and/or statin (e.g., simvastatin, pravastatin)).
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be minimal within the ﬁrst few days of stroke (Altamura et al., 2009;
Binkofski and Seitz, 2004). However, the neural variability resulting
from conventional fMRI tasks presents a challenge for identifying NVU
in this way, and such an approach is inherently limited to the functional
region expected to be activated by the task.
In recent years, more robust means for detecting NVU risk have
emerged. Speciﬁcally, breath-hold CVR mapping, which emerged as a
more convenient alternative to other hypercapnic methods such as ex-
ogenous CO2 administration, is continuing to garner attention for clini-
cal research and application—particularly to augment functional maps
obtained from presurgical tumor patients (Pillai and Mikulis, 2015;
Pillai and Zaca, 2011). This non-invasive technique simply requires pa-
tients to hold their breath for short intervals inside theMR scanner. Re-
gions of impaired CVR are not as effective in modulating blood ﬂow in
response to the induced hypercapnia and can thus be visualized as
areas void of activity in the resulting fMRI maps (Pillai and Mikulis,
2015). This method has previously been used at the group level to con-
ﬁrm the deleterious effects of aging on CVR (Handwerker et al., 2007;
Kannurpatti et al., 2010), although to our knowledge it has been imple-
mented just twice previously for the same purpose in stroke patients
(Geranmayeh et al., 2015; van Oers et al., 2010), the focus being on
the subacute and chronic stages.
Thus, the goal of the present study was to quantitatively assess CVR
and determine the validity of fMRI in stroke patients at the acute stage,
deﬁned in our study as less than ten days after stroke. BOLD parameters
computed from a breath-hold task were compared between stroke pa-
tients and healthy controls at the group level to identify any stroke-re-
lated deﬁcits in CVR that could give rise to NVU. These results are
obtained through two separate analyses in order to compare two com-
mon approaches to accounting for the extended delay of the vascular re-
sponse to hypercapnia relative to neural activity—a standard
adjustment of the breath-holdmodel response for all subjects (standard
delay) (as in (Di et al., 2013)) and an adjustment optimized on an indi-
vidual basis (subject-wise delay) (as in (Bright and Murphy, 2013)).
Based on the ﬁndings of Binkofski and Seitz (Binkofski and Seitz,
2004) and Altamura et al. (Altamura et al., 2009), we hypothesized
that CVR is not yet impaired at a level detectable by fMRI at the acute
stage of stroke. Thus, since CVR deﬁcits have been regularly implicated
in healthy aging (D'Esposito et al., 2003; Riecker et al., 2003), we pre-
dicted that global CVR would be reduced in stroke patients compared
to young controls but would not differ from older, age-matched con-
trols. Additionally, although the degree of CVR impairment has been
found to be especially pronounced in the lesioned hemisphere
(Altamura et al., 2009; Binkofski and Seitz, 2004; Krainik et al., 2005;
Mazzetto-Betti et al., 2010), we expected to observe no differences in
CVR between the ipsilesional and contralesional hemispheres of stroke
patients at this early stage.2. Methods
2.1. Subjects
Twenty-two acute stroke patients (ages 44–75 years, mean =
59 years, 14 male) (Table 1) were included in the study, originally re-
cruited for an ongoing longitudinal project. Inclusion criteria were at
least 18 years of age, ability to provide written informed consent, and
initial scan within 10 days of stroke. Exclusion criteria were history of
psychiatric illness, confounding neurological disorders, drug abuse,
and contraindications to MRI. Twenty-two age-matched healthy con-
trols were also included in the study (ages 50–74 years, mean = 59,
10 male), as well as a group of 22 younger healthy controls (ages 18–
27 years, mean= 22, 11male). The studywas conducted in accordance
with a protocol approved by the local Health Sciences Institutional Re-
view Board. All subjects provided written informed consent.2.2. Data collection
All imaging data were obtained on GE 750 3T MRI scanners (GE
Healthcare, Waukesha, WI) equipped with an eight-channel head coil.
T1-weighted axial anatomical slices were acquired at the beginning of
each session following an FSPGR BRAVO sequence (TR = 8.132 ms,
TE = 3.18 ms, TI = 450 ms, 256 × 256 matrix, 156 slices, ﬂip angle =
12°, FOV= 25.6 cm, slice thickness = 1mm). Functional data were ac-
quired via echo-planar T2*-weighted imaging (TR = 2.0 s, 40 slices, 90
volumes, TE = 22 ms, FOV = 22.4 cm, ﬂip angle = 60°, voxel dimen-
sions 3.75 × 3.75 × 4.0 mm3).
Each breath-hold scan followed a block design consisting of four 20-
s, end-expiration blocks alternating with four 20-s blocks of rest, for a
total scan length of 3 min. Subjects were instructed to begin each task
block with a moderate breath.2.3. Data analysis
All preprocessing of imaging data was performed within the Analy-
sis of Functional Neuroimages (AFNI) suite (Cox, 1996), except where
noted. Subject-speciﬁc gray matter masks were created via automated
segmentation of the skull-stripped anatomical volumes using FSL's
FAST (FMRIB Software Library, Oxford, UK) (Zhang et al., 2001). Func-
tional data were ﬁrst aligned to the anatomical and normalized to stan-
dard Montreal Neurological Institute (MNI) space. The ﬁrst four
volumes were discarded to allow for steady-state imaging. Images
were then resampled to 3.0 mm isotropic, despiked, volume-registered,
and spatially smoothed using a 4-mm full-width at half-maximum
Gaussian kernel. The time serieswithin each voxelwas scaled to percent
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variate hemodynamic response function (HRF) convolvedwith a boxcar
reference waveform and six rigid-body motion parameters and their
derivatives regressed. A composite estimate of head motion was calcu-
lated for each subject as the square root of the sum of squares (Euclide-
an norm) of the twelve motion parameters' (three translational and
three rotational) derivatives (Jones et al., 2010). High-motion time
points (Euclidean norm exceeding 0.3) were censored in the GLM.
2.4. Breath-hold analyses: Standard delay and subject-wise delay
In an initial analysis, the model HRF was delayed by a standard
amount for all subjects (standard delay). A wide range of values have
previously been used for this purpose, from as low as 7 s (Di et al.,
2013) up to 12 s (Kannurpatti et al., 2011). Given the advanced age of
many of the subjects included in the study, we tested a relatively
lengthy delay of 11 s for all subjects.
In a separate analysis, the Hilbert transform (AFNI plugin 3ddelay)
was used to approximate, at each voxel, the temporal shift of the
model HRF needed to best ﬁt the voxel's time course. These delays
were averaged over gray matter and incorporated into the model for
each subject (subject-wise delay) in order to account for the inter-sub-
ject variability in the breath-hold vascular response andpotential delays
due to slower-responding vasculature in older controls or stroke
patients.
2.5. Breath-hold measures and statistical tests
For both the standard and subject-wise analyses, magnitude of acti-
vation from the breath-hold taskwas derived from the beta-weights for
the HRF, which approximate BOLD percent signal change during the
task, while activation volume was determined as the number of voxels
surpassing a liberal threshold of p b 0.01 (uncorrected) (Geranmayeh
et al., 2015). The mean delay of the HRF obtained from 3ddelay was
also averaged over gray matter and compared between groups. One-
way ANOVAs were performed separately for the magnitude, extent,
and delay of BOLD activation, as well as gray matter volume, among
the three groups. To ensure that ipsilesional impairments in CVR were
not overlooked due to averaging with intact contralesional CVR, hemi-
spheric comparisons in stroke patients were performed. Two-tailed
paired t-tests were used to compare the above measures between the
ipsilesional and contralesional hemispheres of patients. Paired t-tests
were also used to compare measures for each group between the two
analyses (standard delay versus subject-wise delay). A p value of
≤0.05 was considered statistically signiﬁcant for all tests. For ANOVAs,
this was determined by Fisher's least signiﬁcant difference (LSD) post-
hoc test. Statistics are represented as mean ± standard deviation.
3. Results
3.1. Motion during breath-hold task
As described above, a composite measure of head motion, the Eu-
clidean norm, was calculated for each subject. An ANOVA revealed sig-
niﬁcant between-group differences in the mean of this motion
estimate (young controls = 0.09 ± 0.03 mm, old controls = 0.11 ±
0.05 mm, stroke = 0.16 ± 0.07 mm; F(2, 63) = 9.94, p b 0.001). As de-
tailed in the previous section, these differences were minimized
through an aggressive motion scrubbing approach in which high-mo-
tion time points were censored before HRF ﬁtting, in addition to the re-
gression of six motion parameters and their derivatives.
3.2. Gray matter volume
The volume of the graymattermask created for each subjectwas, on
average, 85.4 ± 3.7 cm3 for young controls, 78.4 ± 5.9 cm3 for oldcontrols, and 76.4 ± 4.9 cm3 for patients (F(2, 63) = 20.1, p b 0.001).
Due to these being signiﬁcantly different, group activation volumes
are reported as percentages of the average size of the gray matter
mask for each group (Thomason et al., 2005).
Fig. 1 displays group activation maps for both analyses (standard
delay and subject-wise delay). The ﬁgure shows large differences in ac-
tivation volume among the three groups when projected onto a stan-
dard MNI mask for both standard and subject delayed approaches.
However, for quantitative analysis below, much of this was accounted
for by using gray matter masks speciﬁc to these different groups.
3.3. Standard delay
There were signiﬁcant differences in magnitude of BOLD activation,
calculated as the average percent signal change across gray matter
(F(2, 62) = 3.52, p= 0.036). Whereas young controls (1.06 ± 0.27) did
not differ from old controls (0.92 ± 0.27; p = 0.090) or patients
(1.14 ± 0.30; p= 0.369), the BOLD magnitude of patients was signiﬁ-
cantly greater than that of old controls (p= 0.011) (Fig. 2). Differences
in activation volume also reached signiﬁcance (F(2, 63) = 3.18, p =
0.048) as, on average, a signiﬁcantly greater percentage of gray matter
voxels were activated in young controls (44.8 ± 19.8%) compared
with old controls (25.9 ± 25.2%; p = 0.015) (Fig. 3). Differences be-
tween young controls and patients (37.4 ± 29.4) were not signiﬁcant
(p = 0.329), nor were those between old controls and patients (p =
0.133).Magnitude and activation volume in the ipsilesional hemisphere
of stroke patients (1.18±0.39 and 37.0±29.0%, respectively) were not
signiﬁcantly different from the contralesional hemisphere (1.18 ± 0.40
and 38.0 ± 30.3%) (magnitude: t(21) = 0.08, p= 0.939; activation vol-
ume: t(21) = 0.73, p= 0.476).
3.4. Subject-wise delay
Young controls showed the shortest delay in hemodynamic re-
sponse (11.2 ± 2.4 s), followed by stroke patients (11.3 ± 2.1 s),
while the longest delay was observed in old controls (12.6 ± 2.0 s);
however, these differences yielded only a non-signiﬁcant trend
(F(2, 63) = 2.69, p = 0.076) (Fig. 4). Magnitude of BOLD activation
did not signiﬁcantly differ between the three groups (young controls=
1.13± 0.20, old controls= 1.12 ± 0.39, stroke patients = 1.25 ± 0.32;
F(2, 63) = 1.13, p= 0.329) (Fig. 2). However, there were signiﬁcant be-
tween-group differences in activation volume in the subject-wise delay
analysis (F(2, 63)= 3.75, p=0.029),with young controls (49.7±16.7%)
having a signiﬁcantly greater extent of activation than old controls
(29.8 ± 22.6%) (p = 0.008), although not stroke patients (39.1 ±
31.0%) (p=0.149) (Fig. 3). The difference between old controls and pa-
tients did not reach signiﬁcance (p=0.207). The average hemodynam-
ic delay did not differ between the ipsilesional (11.2 ± 2.1 s) and
contralesional (11.3 ± 2.1 s) hemispheres of stroke patients (t(21) =
0.23, p= 0.822). Further, as in the standard delay analysis, there were
no signiﬁcant differences in either magnitude or activation volume be-
tween the ipsilesional (magnitude= 1.24± 0.32; activation volume=
38.8± 30.5%) and contralesional (magnitude= 1.23± 0.34; activation
volume = 39.4 ± 31.9%) hemispheres of stroke patients (magnitude:
t(21) = 0.15, p= 0.884; activation volume: t= 0.55, p= 0.587).
3.5. Comparison of analyses: Standard delay vs. subject-wise delay
The differences in magnitude of activation yielded by the standard
delay and subject-wise delay analyses were not signiﬁcant for young
controls (t(21) = 1.18, p = 0.250) or stroke patients (t(21) = 1.03,
p = 0.317), although using an individualized value for the delay gave
a signiﬁcantly greater magnitude for old controls (t(21) = 3.35, p =
0.003). Activation volume did not signiﬁcantly change between the
analyses for any of the groups; however, unlike for young controls
(t(21) = 1.35, p = 0.191) and patients (t(21) = 1.28, p = 0.215), there
Fig. 1.Average breath-hold fMRI groupmaps from the standard delay (left) and subject-wise delay (right) analyses for young controls (top), old controls (middle), and patients (bottom)
overlaid onMNI 152 template. Functional data shown at p b 0.05with aminimumcluster size of 60 voxels. 11 of the 22 strokemapswere ﬂipped so that all lesioned hemisphereswere on
the left side (displayed to the right in this ﬁgure).
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subject-wise delay analysis for old controls (t(21) = 1.86, p= 0.077).
4. Discussion
fMRI is a powerful tool that is commonly used to non-invasively lo-
calize neural activity in the human brain, although its clinical applica-
tion has been limited for a variety of reasons (Jezzard and Buxton,
2006; Pillai, 2010). One limitation, NVU, may compromise the validity
of the BOLD signal in several patient populations, including brain
tumor (Hou et al., 2006; Ulmer et al., 2003), Alzheimer's disease
(Iadecola, 2004), cerebrovascular disease (del Zoppo, 2010; Pineiro et
al., 2002; Roc et al., 2006), and healthy aging (D'Esposito et al., 2003;
Riecker et al., 2003). There is currently a limited understanding of the
sequence of events that link neural activity to a hemodynamic response,
but in theory, a disruption at any stage in this sequence could result in
NVU (Hillman, 2014; Pillai and Mikulis, 2015).
Many studies have indicated the presence of NVU in stroke patients,
although it remains unclear exactly how soon after a stroke NVUbecomes a signiﬁcant concern. fMRI has been used to characterize
brain changes from just days after a stroke to severalmonths afterward,
as results from functional imaging studies have informed our under-
standing of the prolonged time course of stroke recovery (e.g., (Saur et
al., 2006; Ward et al., 2003)). In the present study, we focused on
acute stroke patients less than 10 days from stroke. We used a breath-
hold task to quantify any disparities in CVR in these patients at the
group level relative to healthy controls. Moreover, we analyzed the
resulting BOLD response by ﬁtting it with an HRF that was either de-
layed by a standard amount for all subjects, as is often done to account
for the slower vascular response to hypercapnia versus neural activity,
or by an amount that was optimized for each subject, accounting for dif-
ferences in this hemodynamic delay.
Our standard delay analysis, interestingly, revealed a signiﬁcantly
greater magnitude of the breath-hold response in patients compared
to old controls. The reason for this is unclear, but this could be due to
a combination of the poor ﬁt of the standard delay model for old con-
trols as well as increased motion in the patient group, although a strin-
gent motion censoring approach was undertaken. The subject-wise
Fig. 2.Mean percent signal change in gray matter observed in the BOLD signal during the
breath-hold task. Group averages are shown for both standard delay (left) and subject-
wise delay (right) analyses. One patient data point from the standard delay was treated
as an outlier as it was greater than three standard deviations from the group mean and
is not represented here. ⁎p b 0.05.
Fig. 4. Delay (in seconds) needed for the canonical HRF to optimally ﬁt the time course
from each voxel, averaged over each subject's gray matter.
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the activation volume of young controls was greater than old controls
but not patients. Importantly, neither analysis indicated impaired CVR
in the patient group beyond that of age-matched controls. Furthermore,
we observed no differences in the breath-hold response between the
ipsilesional and contralesional hemispheres of patients. The ﬁndings
from our study suggest that fMRI may still be valid at the acute stage
of stroke, particularly for group comparisonswith healthy age-matched
subjects.
When considered in the context of existing stroke literature, it may
be that NVU ﬁrst appears at some point beyond the acute stage. This
idea is supported by two longitudinal evaluations of the BOLD signal
after stroke. Binkofski and Seitz (Binkofski and Seitz, 2004) found
task-induced activation volume to be transiently decreased 2–4 weeks
after a stroke, relative to both 1 week and 1 month after the stroke,
while transcranial magnetic stimulation was used to verify neural re-
sponses at each time point. Similarly, dynamic BOLD activation was de-
scribed by Altamura et al., who observed hemodynamic impairment at
the subacute, but not the acute, stage. Although the subacute range inFig. 3.Mean activation volume (as a percentage of graymatter) resulting from the breath-
hold task, as calculated from the standard delay (left) and subject-wise delay (right)
analyses. * p b 0.05.their study, 5–12 days after stroke, had considerable overlap with the
present study, the average time since stroke in the present study falls
just below this range. It is possible that cerebrovascular changes begin
to take place during this range, becoming more apparent in the latter
part. More longitudinal studies are necessitated to address such
questions.
In addition to our observations in stroke patients, our results from
both analyses also support the notion that increasing age adversely im-
pacts the BOLD signal (D'Esposito et al., 2003; Riecker et al., 2003;
Tsvetanov et al., 2015). While fMRI still receives widespread use for el-
derly subjects, comparisonswith younger subjects should acknowledge
differences in vasculature. The purpose of our standard versus subject-
wise delay analysis was to draw attention to the practice of shifting
the breath-hold HRFmodel by an equivalent amount for a group of sub-
jects with variable CVR (e.g., Di et al., 2013; Kannurpatti et al., 2011),
rather than modeling the response on an individual basis. Although
both approaches yielded the same pattern of results, the more individ-
ualized, subject-wise delay analysis showed signiﬁcantly increased acti-
vation volume in old controls—the group with the greatest
hemodynamic delay. This ﬁnding highlights the importance of the
delay chosen for analysis of breath-hold data, as a standard HRF delay
used for subjects of varying ages may inadvertently favor younger sub-
jects when determining active voxels. This may represent a larger prob-
lem in cognitive neuroscience research, in which a standard model
based on young healthy subjects is regularly used for all subjects
(Aguirre et al., 1998; D'Esposito et al., 2003; Handwerker et al., 2004).
Such modeling may overlook neural activity in non-typical subjects
that induces a measureable but less predictable vascular response. The
use of an end-tidal CO2 trace as a GLM regressor has been promising
for improving the accuracy of breath-hold response modeling (Bright
andMurphy, 2013; Geranmayeh et al., 2015; Lipp et al., 2015), although
this does not apply to the modeling of traditional fMRI task paradigms.
4.1. Breath-hold CVR mapping in stroke
The present study utilized breath-hold CVR mapping, which is only
starting to become utilized in the stroke population. The primary use
of this technique has been for evaluating hemodynamic responsiveness
in patients – particularly neurosurgical patients – in order to identify re-
gions in which the BOLD signal from a task can be expected to be atten-
uated (Pillai and Mikulis, 2015). Its correspondence with other
validated methods for evaluating CVR has been demonstrated (Biswal
et al., 2007; Kastrup et al., 2001). In stroke patients, the importance of
such a procedure becomes especially apparent when attempting to
compare neuroimaging data with healthy controls or evaluate changes
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studies have utilized a breath-hold task in stroke patients; interestingly,
like the present study, both failed to observe perturbed CVR. In an fMRI
study of recovery from aphasia, vanOers et al. (vanOers et al., 2010) im-
plemented a breath-hold task to validate their comparisons from func-
tional imaging by showing that subacute and chronic stroke patients
did not differ from controls in CVR. Recently, Geranmayeh et al.
(Geranmayeh et al., 2015) also found no differences in CVR in the
healthy tissue of subacute and chronic stroke patients and controls.
However, the negative ﬁndings of these studies contradict much of
the literature in chronic stroke. Perhaps more importantly, though,
these studies demonstrate the ease and efﬁcacy of a breath-hold task
to increase conﬁdence in group functional imaging studies involving
chronic stroke patients. Similarly, our study serves this purpose for
acute patients.
Given that all three breath-hold studies have indicated CVR to be un-
affected in stroke, it is important to note that intact CVR is not equiva-
lent to intact neurovascular coupling. It is plausible in some cases that
the ability of vascular smoothmuscle cells tomodulate bloodﬂow in re-
sponse to hypercapnia is preserved at the same time that the response
to extravascular (e.g., neural) stimulation is compromised. While CVR-
basedmethods of predicting NVU assume a commonmechanism to un-
derlie deﬁcits in both, such as an overall reduced capacity for vasodila-
tion, NVU may actually be the result of dysfunction at an earlier stage
of the functional hyperemic process—anywhere from the release or syn-
thesis of vasoactive agents in response to neural activity to the binding
of these agents, to their corresponding pathways that would otherwise
result in vasodilation (Girouard and Iadecola, 2006). BOLD CVR map-
ping does not exactly test neurovascular coupling, per se, and thus
may be of little use in such cases of upstreamneurovascular dysfunction
(DeYoe and Raut, 2014; Pillai and Mikulis, 2015). This possibility de-
serves particular consideration in ischemic stroke due to the selective
changes in the neurovascular unit that may occur. For example, astro-
cytes, which link synaptic activity to capillaries and arterioles and thus
play a critical role in neurovascular coupling, are often damaged in the
stroke event or functionally altered afterward (Pekny and Nilsson,
2005). To the best of our knowledge, there has not yet been a demon-
stration of impairment at an earlier stage of the coupling process with
a preserved vasodilatory response to hypercapnia, but this remains a
theoretical possibility.
4.2. Limitations and future directions
Our study had multiple experimental limitations that should be
taken into consideration. For one, it is known that differences in
breath-hold task performance can confound CVR comparisons
(Kannurpatti et al., 2014). Thus, it may be important in future studies
to collect physiological data and CO2 recordings in order to verify proper
performance of all study subjects on the breath-hold task and improve
estimates of CVR (Lipp et al., 2015). In the present study, because no dif-
ferences in CVRwere observed between patients and age-matched con-
trols, it is unlikely that performance was a major issue in the patient
group.
Head motion can also become an important concern when working
with patient imagingdata. The patient group in thepresent study exhib-
ited more head motion than both groups of controls, and old controls
exhibited more head motion than young controls. Although we took
an aggressive approach to minimize the risk of head motion obscuring
differences in CVR, task-related motion may still have impacted the
data, potentially increasing the number of voxels exhibiting task-associ-
ated activity aswell as the estimatedmagnitude of BOLDactivation. This
possibility is acknowledged and highlights one of the most persistent
challenges in fMRI research and, in particular, its clinical application.
Finally, the heterogeneity in our patient sample with respect to fac-
tors such as type of stroke, location, lesion volume, treatment, and time
after stroke onsetmay have contributed to the high variability observed,making an effectmore difﬁcult to identify. For example, differencesmay
exist between cortical and subcortical or supratentorial and
infratentorial strokes, or strokes in regions supplied by different major
arteries, all of which are included in our sample; however, the extent
to which these would differentially affect CVR is unknown. Moreover,
changes in the brain can occur quickly in the days following stroke
onset, and so the variability in time after onset in our sample could po-
tentially represent different stages in the recovery process. More gener-
ally, the course of CVRmay be radically different from patient to patient
for a number of reasons, and it is possible that any impairments in CVR
were averaged out at the group level. Reduced CVR may also be highly
focal to the lesion and could have been overlooked when averaging
over whole-brain gray matter. To account for this, we compared
ipsilesional and contralesional CVR at a group level and conﬁrmed our
negative ﬁndings, although it is possible that even averaging over a
hemisphere is enough to mask reduced CVR inside and proximal to
the lesioned area. In short, the highly variable results among patients
in our study still warrant precaution when interpreting data from indi-
vidual patients. In the future, to overcome some limitations of the pres-
ent study, it would be useful to perform similar analyses in a more
homogenous and larger stroke sample.5. Conclusion
Herewe used a breath-hold task to evaluate CVR shortly after stroke.
NVU has received increased attention in recent years, particularly in pa-
tient populations such as stroke. However, our ﬁndings suggest that
NVU due to compromised CVR is likely not a serious concern for group
comparisons of fMRI data between acute stroke patients and age-
matched controls. Thus, group differences in these studies can likely
be attributed to brain activity differences. Nonetheless, given the effect
of stroke on vasculature and the high variability in CVR observed here,
researchers and clinicians should remain cognizant of the limitations
of fMRIwhen dealingwith patients at any stage of stroke. In future stud-
ies, itwill be useful to includemore homogenous patient samples and to
obtain CO2 recordings to improve the accuracy of breath-hold data.Acknowledgments
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